CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377). Issue 3 (September 2020) - Jordan, Stanley; Ammerman, Noriko; Toyoda, Mieko; Ge, Shili; Huang, Edmund; Peng, Alice; Sethi, Supreet; Najjar, Reiad; Ortiz, Edwin; Chu, Maggie; De Guzman, Abner; Kim, Irene; et al.